Ketamine acts primarily through non-competitive NMDA receptor antagonism but has myriad downstream effects. Previously best known as an anaesthetic, analgesic or substance of abuse, it is now part of psychiatry’s toolkit as an anti-depressant (Price et al., 2022). Ketamine is also useful as a model of psychosis, reproducing symptoms and allowing examination of corresponding brain states. It was...